| |
Surgery n(%) |
Conservative n(%) |
| |
non malignancy |
malignant disease |
n.i.1 |
total |
non malignancy |
malignant disease |
n.i.1 |
total |
| |
19 (30) |
44 (70) |
|
63 (58) |
8 (17) |
38 (83) |
|
46 (42) |
| mean age (years) |
|
|
|
68 |
|
|
|
65 |
| female |
|
|
|
45 (71) |
|
|
|
31(67) |
| Underlying disease |
|
|
|
|
|
|
|
|
| Multiple Myeloma |
|
14 (32) |
|
|
|
10 (26) |
|
|
| Breast cancer* |
|
21(48) |
|
|
|
18 (47) |
|
|
| prostate cancer |
|
6 (14) |
|
|
|
4 (11) |
|
|
| others* |
|
4* (9) |
|
|
|
6 (16) |
|
|
| drug regimen* |
|
|
|
|
|
|
|
|
| zoledronic acid |
4 *** |
36 |
|
40(63) |
1 |
32 |
|
33 (72) |
| pamidronate |
3 |
8 |
|
11 |
2 |
5 |
|
7 |
| alendronate |
7 |
1 |
|
8 |
4 |
1 |
|
5 |
| ibandronate |
9 |
1 |
|
10 |
2 |
|
|
2 |
| others |
0 |
7 |
|
7 |
1 |
1 |
|
2 |
| duration of BP(months)** |
43 |
37 |
3 |
39 |
31 |
28 |
9 |
28 |
| local risk factor |
|
|
|
|
|
|
|
|
| extraction |
11 |
26 |
|
37 (59) |
3 |
25 |
|
28(61) |
| prosthesis |
5 |
9 |
|
14 |
2 |
2 |
|
4 |
| implants |
3 |
6 |
|
9 |
3 |
0 |
|
3 |
| periodontal disease |
1 |
5 |
|
6 |
0 |
3 |
|
3 |
| Dental infection |
4 |
10 |
|
14 (22) |
2 |
10 |
|
22(26) |
| duration of PB stopp (months) |
5 |
6 |
|
6 |
|
|
|
|
| general anaesthesia |
|
|
|
55 (87) |
|
|
|
|
| local anaesthesia |
|
|
|
8 |
|
|
|
|
| outcome |
|
|
|
|
|
|
|
|
| complete remission |
18 (95) |
31(70) |
|
49(78) |
|
|
|
|
| partial remission |
1 |
7 |
|
8(13) |
|
|
|
|
| no improvement |
0 |
6 |
|
6 |
|
|
|
|
| |
|
|
|
|
|
|
|
|
| 1 no information |
|
|
|
|
|
|
|
|
| *patient may belong to more than one group
|
| **until the first presentation |
| *** all patients received zoledronic acid 1/year |
|
